Endocrinological aspects of proteinuria and podocytopathy in diabetes: role of the aldosterone/mineralocorticoid receptor system.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Diabetes Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157339911794273919PMID 21067506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mineralocorticoid Receptor Blockade Enhances the Antiproteinuric Effect of an Angiotensin II Blocker through Inhibiting Podocyte Injury in Type 2 Diabetic Rats

  2010cited by this paper
• Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt.

  2009cited by this paper
• Mouse models of diabetic nephropathy.

  2009cited by this paper
• Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.

  2009cited by this paper
• Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

  2009cited by this paper
• Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

  2009cited by this paper
• Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.

  2009cited by this paper
• A Role for the CHC22 Clathrin Heavy-Chain Isoform in Human Glucose Metabolism

  2009cited by this paper
• Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines

  2008cited by this paper
• Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.

  2008cited by this paper
• Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.

  2008cited by this paper
• Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

  2008cited by this paper
• Salt-Induced Nephropathy in Obese Spontaneously Hypertensive Rats Via Paradoxical Activation of the Mineralocorticoid Receptor: Role of Oxidative Stress

  2007cited by this paper
• The incidence and implications of aldosterone breakthrough

  2007cited by this paper
• Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1

  2007cited by this paper
• Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone Blocker

  2006cited by this paper
• Rho Family Guanine Nucleotide Exchange Factor Brx Couples Extracellular Signals to the Glucocorticoid Signaling System*

  2006cited by this paper
• Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.

  2006cited by this paper
• Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.

  2006cited by this paper
• Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy.

  2006cited by this paper
• Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

  2006cited by this paper
• Podocyte lesions in patients with obesity-related glomerulopathy.

  2006cited by this paper
• Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.

  2006cited by this paper
• Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.

  2006cited by this paper
• Aldosterone blockade: an emerging strategy for abrogating progressive renal disease.

  2006cited by this paper
• Renal Damage in Primary Aldosteronism: Results of the PAPY Study

  2006cited by this paper
• Hereditary proteinuria syndromes and mechanisms of proteinuria.

  2006cited by this paper
• Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible

  2006cited by this paper
• Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

  2006cited by this paper
• Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes

  2006cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.

  2006cited by this paper
• Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

  2006cited by this paper
• Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Failure in Low-Aldosterone Hypertensive Rats

  2006cited by this paper
• Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes.

  2006cited by this paper
• Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria

  2005cited by this paper
• Beneficial impact of spironolactone in diabetic nephropathy.

  2005cited by this paper
• Expression and regulation of adrenomedullin in renal glomerular podocytes.

  2005cited by this paper
• Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization.

  2005cited by this paper
• Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization

  2005cited by this paper
• Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor

  2005cited by this paper
• A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis

  2005cited by this paper
• Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage

  2005cited by this paper
• Aldosterone as a cardiovascular risk factor.

  2005cited by this paper
• Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.

  2005cited by this paper
• Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.

  2005cited by this paper
• Mouse models of diabetic nephropathy.

  2005cited by this paper
• From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

  2005cited by this paper
• TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function

  2005cited by this paper
• Relative glomerular hyperfiltration in primary aldosteronism.

  2005cited by this paper
• 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.

  2004cited by this paper
• Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat

  2004cited by this paper
• Possible Contributions of Reactive Oxygen Species and Mitogen-Activated Protein Kinase to Renal Injury in Aldosterone/Salt-Induced Hypertensive Rats

  2004cited by this paper
• Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

  2004cited by this paper
• Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

  2004cited by this paper
• Activation of a local tissue angiotensin system in podocytes by mechanical strain.

  2004cited by this paper
• Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.

  2004cited by this paper
• Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration

  2004cited by this paper
• The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

  2004cited by this paper
• Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes

  2004cited by this paper
• Aldosterone in chronic kidney and cardiac disease.

  2003cited by this paper
• Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy

  2003cited by this paper
• Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.

  2003cited by this paper
• Cell biology of the glomerular podocyte.

  2003cited by this paper
• Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.

  2003cited by this paper
• Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.

  2003cited by this paper
• Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.

  2003cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Recent landmark clinical trials: how do they modify the therapeutic paradigm?

  2002cited by this paper
• Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

  2002cited by this paper
• Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress

  2002cited by this paper
• Rho GTPases as Modulators of the Estrogen Receptor Transcriptional Response*

  2001cited by this paper
• Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• Aldosterone in congestive heart failure.

  2001cited by this paper
• Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-&kgr;B Activation in Angiotensin II–Induced Cardiac Injury

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome

  2000cited by this paper
• Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

  2000cited by this paper
• Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIα

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Congenital nephrotic syndrome in mice lacking CD2-associated protein.

  1999cited by this paper
• Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.

  1999cited by this paper
• Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

  1999cited by this paper
• Catecholamines modulate podocyte function.

  1998cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper
• Podocyte loss and progressive glomerular injury in type II diabetes.

  1997cited by this paper
• Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats.

  1997cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Role of aldosterone in the remnant kidney model in the rat.

  1996cited by this paper
• Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat

  1996cited by this paper
• Albuminuria in untreated patients with primary aldosteronism or essential hypertension

  1995cited by this paper
• Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

  1995cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Characterization of renal aldosterone receptors in genetically hypertensive rats.

  1993cited by this paper
• Adrenalectomy ameliorates ablative nephropathy in the rat independently of corticosterone maintenance level.

  1992cited by this paper
• Adriamycin-induced increase in serum aldosterone levels: effects in riboflavin-sufficient and riboflavin-deficient rats.

  1990cited by this paper
• Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.

  1984cited by this paper
• Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.

  1981cited by this paper
• CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

  1964cited by this paper

• Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

  2026cites this paper
• Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease

  2021cites this paper
• Extracellular matrix induced by steroids and aging through a G-protein-coupled receptor in a Drosophila model of renal fibrosis

  2020cites this paper
• Mineralocorticoid receptor excessive activation involved in glucocorticoid-related brain injury.

  2019cites this paper
• Extra-cellular matrix induced by steroids through a G-protein coupled receptor in a Drosophila model of renal fibrosis

  2019cites this paper
• Effects of p53 on aldosterone-induced mesangial cell apoptosis in vivo and in vitro

  2016cites this paper
• The role of aldosterone antagonism agents in diabetic kidney disease.

  2015cites this paper
• Stress oxydant et effets bénéfiques rénaux de la restriction sodée dans l’insulinorésistance chez le rat

  2012cites this paper
• [Oxydative stress and beneficial effect of sodium restriction on kidney damage associated with insulin resistance in rats].

  2012cites this paper
• Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats

  2012cites this paper